Al-Razi Medical Company (TADAWUL:9572)

Al-Razi Medical Company Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 3, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	42	90	91	-	-
Market Cap Growth	-51.85%	-1.34%	-	-	-
Enterprise Value	55	98	97	-	-
Last Close Price	27.54	59.00	59.80	-	-
PE Ratio	148.60	509.93	132.51	-	-
PS Ratio	0.65	1.46	1.48	-	-
PB Ratio	1.84	3.96	4.06	-	-
P/TBV Ratio	1.86	4.03	4.15	-	-
P/FCF Ratio	51.53	81.55	91.19	-	-
P/OCF Ratio	10.64	18.09	15.73	-	-
EV/Sales Ratio	0.85	1.60	1.59	-	-
EV/EBITDA Ratio	10.68	36.62	32.66	-	-
EV/EBIT Ratio	38.63	94.35	62.66	-	-
EV/FCF Ratio	67.28	89.31	97.71	-	-
Debt / Equity Ratio	0.58	0.38	0.48	0.32	0.27
Debt / EBITDA Ratio	2.56	1.78	2.04	1.45	1.49
Debt / FCF Ratio	16.11	7.86	10.73	-	-
Net Debt / Equity Ratio	0.56	0.34	0.44	0.26	-0.05
Net Debt / EBITDA Ratio	4.08	2.88	3.30	1.68	-0.36
Net Debt / FCF Ratio	15.75	7.03	9.87	-9.51	0.43
Asset Turnover	1.34	1.42	1.39	1.26	-
Inventory Turnover	2.21	2.23	1.98	1.84	-
Quick Ratio	0.29	0.27	0.14	0.19	0.89
Current Ratio	1.56	1.92	1.79	2.07	2.61
Return on Equity (ROE)	1.25%	0.78%	2.99%	8.43%	-
Return on Assets (ROA)	1.85%	1.51%	2.20%	3.88%	-
Return on Invested Capital (ROIC)	1.71%	1.10%	3.17%	8.12%	8.99%
Return on Capital Employed (ROCE)	4.20%	3.50%	5.00%	8.60%	8.20%
Earnings Yield	0.67%	0.20%	0.76%	-	-
FCF Yield	1.94%	1.23%	1.10%	-	-
Dividend Yield	5.76%	-	2.65%	-	-
Payout Ratio	-	-	351.72%	93.81%	-
Total Shareholder Return	5.81%	-	2.65%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.